ID   HSY
AC   CVCL_B032
DR   BioSample; SAMN03151716
DR   BioSample; SAMN03471294
DR   Cosmic; 974318
DR   GEO; GSM1132848
DR   GEO; GSM1132849
DR   GEO; GSM1132850
DR   GEO; GSM1132851
DR   GEO; GSM1132856
DR   GEO; GSM1132857
DR   GEO; GSM1132858
DR   GEO; GSM1132859
DR   GEO; GSM1132860
DR   GEO; GSM1132861
DR   JCRB; CHB0001
DR   Wikidata; Q54896488
RX   DOI=10.1007/0-306-46872-7_9;
RX   PubMed=2446043;
RX   PubMed=20143388;
RX   PubMed=29923277;
WW   https://iclac.org/wp-content/uploads/Cross-Contaminations_v12_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=20143388; PubMed=29923277). Originally thought to originate from a 51 year old female patient with a parotid gland adenocarcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00317.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Transcriptome analysis by microarray.
CC   Discontinued: JCRB; CHB0001; probable.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): JCRB; PubMed=29923277
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D5S818: 11
ST   D7S820: 8,12
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 05-10-23; Version: 19
//
RX   DOI=10.1007/0-306-46872-7_9;
RA   Sato M.;
RT   "Salivary gland tumors.";
RL   (In) Human cell culture. Vol. 1. Cancer Cell Lines part 1; Masters J.R.W., Palsson B.O. (eds.); pp.161-178; Kluwer Academic Publishers; New York (1999).
//
RX   PubMed=2446043; DOI=10.1093/jnci/79.5.1025;
RA   Hayashi Y., Yanagawa T., Yoshida H., Azuma M., Nishida T., Yura Y.,
RA   Sato M.;
RT   "Expression of vasoactive intestinal polypeptide and amylase in a
RT   human parotid gland adenocarcinoma cell line in culture.";
RL   J. Natl. Cancer Inst. 79:1025-1037(1987).
//
RX   PubMed=20143388; DOI=10.1002/ijc.25242;
RA   Capes-Davis A., Theodosopoulos G., Atkin I., Drexler H.G., Kohara A.,
RA   MacLeod R.A.F., Masters J.R.W., Nakamura Y., Reid Y.A., Reddel R.R.,
RA   Freshney R.I.;
RT   "Check your cultures! A list of cross-contaminated or misidentified
RT   cell lines.";
RL   Int. J. Cancer 127:1-8(2010).
//
RX   PubMed=29923277; DOI=10.1111/odi.12920;
RA   Lin L.-C., Elkashty O., Ramamoorthi M., Trinh N., Liu Y.-N.,
RA   Sunavala-Dossabhoy G., Pranzatelli T., Michael D.G., Chivasso C.,
RA   Perret J., Chiorini J.A., Delporte C., Tran S.D.;
RT   "Cross-contamination of the human salivary gland HSG cell line with
RT   HeLa cells: a STR analysis study.";
RL   Oral Dis. 24:1477-1483(2018).
//